Effectiveness of Propolis Mouthwash on Gingivitis

Overview

Mouthrinses have been in used for centuries as breath fresheners, medicaments, and antiseptics. Recently, propolis has caught the eyes of dentists worldwide and researches are being carried out to infuse the usage of propolis in the dental health care treatments. There is belief that propolis may have a role as a tooth decay prophylaxis and help heal oral ulcers. Propolis is used as mouthwash, toothpaste, oral gel, and throat lozenges because of its proclaimed antibacterial and anti-inflammatory properties. Propolis has shown activity against common periodontal microorganisms, such as Candida species and the Streptococci mutans in vitro studies. Till date, no study has evaluated the clinical and microbiological effects of Malaysian Propolis as a mouthwash. Thus, the present study is designed to evaluate the effectiveness of Propolis as a mouthwash in the reduction of Plaque and gingivitis.The aim of the study is to assess and compare the effectiveness of Propolis mouthrinse with Chlorhexidine mouthrinse.

Full Title of Study: “Comparison of Effectiveness of Propolis Mouthwash on Gingivitis – Randomized Controlled Clinical Study”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Crossover Assignment
    • Primary Purpose: Prevention
    • Masking: Double (Investigator, Outcomes Assessor)
  • Study Primary Completion Date: March 11, 2019

Detailed Description

The Randomized Controlled Clinical study with latin-square cross-over design would be used to assess and compare the effectiveness of Propolis and Chlorhexidine mouthrinse on gingivitis. Subjects with chronic generalized gingivitis with age group of 18-30 years will be selected for the study as the target population. Subjects who meet the inclusion and exclusion criteria will be selected and screened for the plaque and gingival status before including them in the study. They will be randomly divided into three groups. Group 1: 15 subjects (Placebo mouthwash) Group 2: 15 subjects (Propolis mouthwash) Group 3: 15 subjects (Chlorhexidine mouthwash)

Interventions

  • Drug: Placebo mouthwash
    • After using mouthwash for 21 days, they are instructed to refrain from mouthwash for 14 days (wash out period).
  • Drug: Propolis mouthwash
    • After using mouthwash for 21 days, they are instructed to refrain from mouthwash for 14 days (wash out period).
  • Drug: Chlorhexidine mouthwash
    • After using mouthwash for 21 days, they are instructed to refrain from mouthwash for 14 days (wash out period).

Arms, Groups and Cohorts

  • Placebo Comparator: Placebo
    • Subjects were asked to rinse 10 ml of mouthwash twice daily for 21 days.
  • Experimental: Propolis
    • Subjects were asked to rinse 10 ml of mouthwash twice daily for 21 days.
  • Active Comparator: Chlorhexidine
    • Subjects were asked to rinse 10 ml of mouthwash twice daily for 21 days.

Clinical Trial Outcome Measures

Primary Measures

  • Change in Gingival Index (GI)
    • Time Frame: Difference for the mean gingival score from baseline to 21 days.
    • The primary outcome variable was the differences for the mean gingival score from baseline to 21 days. The gingival index ranges from 0-3 which is a continuous scale. ‘0’ indicates normal healthy gingiva without inflammation (better score) ; and score ‘3’ indicates severe gingival inflammation (worst score). The index teeth of each participant were examined and gingival status is scored. The score for each subject is added and divided by the total number of teeth examined. The average/mean gingival score obtained from each subject is added for all the subjects and divided by the total number of participants. Higher score indicates worst score.
  • Change in Plaque Index (PI)
    • Time Frame: Difference in the mean reduction of Plaque score from baseline to 21 days.
    • The primary outcome variable was the differences for the mean plaque score from baseline to 21 days. The plaque index ranges from 0-3 which is a continuous scale. ‘0’ indicates no plaque on teeth (better score) ; and score ‘3’ indicates abundance of plaque on the teeth (worst score). The index teeth of each participant were examined and plaque score is recorded. The score for each subject is added and divided by the total number of teeth examined. The average/mean plaque score obtained from each subject is added for all the subjects and divided by the total number of participants. Higher score indicates worst score.

Participating in This Clinical Trial

Inclusion Criteria

  • Gingival index >1 – Periodontal pocket depth ≤ 3 mm – Clinical attachment loss "0" – Provision of written informed consent – Good systemic health. Exclusion Criteria:

  • Severe periodontal disease, as characterized by purulent exudates, generalized mobility, and/or severe recession – Any condition that requires antibiotic premedication for the administration of a dental prophylaxis. – Self-reported pregnancy, intent to become pregnant during the study, or breast-feeding. – Any diseases or condition that could be expected to interfere with the safe completion of the study. – History of antibiotic use in the previous 3 months. – Individuals with orthodontic appliances or prosthetic appliances that would interfere with evaluation.

Gender Eligibility: All

Minimum Age: 20 Years

Maximum Age: 30 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Mahsa University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Shilpa Gunjal, Associate Professor – Mahsa University
  • Overall Official(s)
    • Shilpa Gunjal, Ph.D, Principal Investigator, Mahsa University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.